tiprankstipranks
Trending News
More News >
Addus HomeCare Corporation (ADUS)
:ADUS
Advertisement

Addus Homecare (ADUS) AI Stock Analysis

Compare
350 Followers

Top Page

ADUS

Addus Homecare

(NASDAQ:ADUS)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 4o)
Rating:79Outperform
Price Target:
$136.00
▲(19.10% Upside)
Addus Homecare's strong financial performance and positive earnings call are the most significant factors contributing to its score. The company's strategic acquisitions and revenue growth in the personal care segment highlight its growth potential. However, valuation concerns and challenges in the home health segment slightly temper the overall outlook.
Positive Factors
Revenue Growth
The significant revenue growth indicates strong market demand and effective business strategies, supporting long-term expansion and sustainability.
Strategic Acquisitions
Strategic acquisitions enhance market presence and service capabilities, providing a competitive edge and supporting sustained growth.
Cash Flow Management
Strong cash flow management ensures financial stability and flexibility, enabling investments in growth opportunities and debt reduction.
Negative Factors
Home Health Segment Challenges
Declining revenue in the home health segment highlights operational challenges and potential risks to overall business performance.
Medicare Payment Concerns
Potential Medicare cuts could impact revenue streams and profitability, posing a risk to financial stability and strategic planning.
Urban Hiring Challenges
Hiring challenges in urban areas may affect service delivery and growth potential, limiting the company's ability to meet demand.

Addus Homecare (ADUS) vs. SPDR S&P 500 ETF (SPY)

Addus Homecare Business Overview & Revenue Model

Company DescriptionAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
How the Company Makes MoneyAddus Homecare generates revenue primarily through the provision of home care services, which are reimbursed by various payers, including Medicare, Medicaid, and private insurance companies. The company's revenue model is predominantly fee-for-service, where they bill for the hours of care provided to clients. Key revenue streams include personal care services, skilled nursing services, and therapy services. Additionally, partnerships with healthcare providers and payers enhance their service offerings and patient access, contributing to the overall growth and stability of their earnings. As the demand for home care services continues to rise due to an aging population and a shift towards home-based care, Addus Homecare's revenue potential is bolstered by these market trends.

Addus Homecare Earnings Call Summary

Earnings Call Date:Nov 03, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 02, 2026
Earnings Call Sentiment Neutral
The earnings call displayed strong revenue growth and successful expansion through acquisitions, particularly in the personal care segment. However, there are challenges in the home health sector due to potential Medicare payment cuts and hiring difficulties in urban areas. The positive momentum in personal care and strategic acquisitions indicate future growth potential.
Q3-2025 Updates
Positive Updates
Strong Revenue and EBITDA Growth
Total revenue for Q3 2025 was $362.3 million, a 25% increase compared to Q3 2024. Adjusted EBITDA increased by 31.6% to $45.1 million.
Significant Personal Care Segment Growth
Personal care segment saw a 6.6% same-store revenue growth with a 2.4% increase in hours per business day. The Texas and Illinois rate increases are expected to contribute approximately $35.2 million in annualized revenue.
Expansion Through Acquisitions
Acquisition of Del Cielo Home Care Services in South Texas, adding $12.7 million in annualized revenue. Previous acquisitions in 2025 include Gentiva and Helping Hands, expanding market presence.
Improved Hiring Performance
Achieved 113 hires per business day, a 6.6% increase over the previous quarter. Strong hiring trends supported organic growth.
Negative Updates
Home Health Revenue Decline
Same-store revenue for home health decreased by 2.8% compared to Q3 2024. Challenges in achieving growth due to rate uncertainty.
Medicare Payment Concerns
Potential 6.4% aggregate reduction in Medicare payments to home health agencies in 2026, creating uncertainty and affecting acquisition opportunities.
Challenges in Urban Clinical Hiring
Ongoing difficulties in hiring skilled clinical staff in urban markets, impacting service delivery.
Company Guidance
During Addus HomeCare's Third Quarter 2025 Earnings Conference Call, the company reported a total revenue of $362.3 million, marking a 25% increase from the same quarter in 2024. This growth translated to an adjusted earnings per share of $1.56, up 20% from the prior year's $1.30. The company's adjusted EBITDA reached $45.1 million, reflecting a 31.6% increase. Addus highlighted strong operating cash flow exceeding $50 million and ended the quarter with $102 million in cash and a net leverage of under 1x adjusted EBITDA. The company noted a 6.6% same-store revenue growth in its personal care segment, with a 2.4% increase in same-store hours and significant hiring momentum, achieving 113 hires per business day, up 6.6% from the previous quarter. In the hospice segment, same-store revenue grew by 19% year-over-year, with a 9.5% increase in the average daily census. Conversely, the home health segment saw a 2.8% decline in same-store revenue. Key developments included a 9.9% rate increase in Texas and an impending 3.9% increase in Illinois, both contributing to substantial revenue growth forecasts. The company also emphasized its acquisition strategy, notably the recent acquisition of Del Cielo's personal care operations, enhancing its market presence in Texas.

Addus Homecare Financial Statement Overview

Summary
Addus Homecare exhibits a strong financial profile with consistent revenue growth, solid profitability margins, and effective cash flow management. The company's low leverage and robust equity position provide a stable foundation for future growth. While the growth rate has slightly decelerated, strategic initiatives could help sustain long-term performance.
Income Statement
85
Very Positive
Addus Homecare has demonstrated strong revenue growth with a 5.16% increase in the TTM period, building on consistent annual growth. The company maintains healthy margins, with a gross profit margin of 32.59% and a net profit margin of 6.51% in the TTM. EBIT and EBITDA margins are also robust, indicating efficient operations. However, the slight decline in revenue growth rate compared to previous years suggests a need for strategic initiatives to sustain momentum.
Balance Sheet
78
Positive
The balance sheet reflects a solid financial position with a low debt-to-equity ratio of 0.22, indicating prudent leverage management. Return on equity is stable at 8.43%, showcasing effective use of shareholder funds. The equity ratio stands at 72.54%, highlighting a strong equity base relative to assets. While the company has reduced debt levels, maintaining this trajectory will be crucial to mitigate potential risks.
Cash Flow
82
Very Positive
Cash flow analysis reveals a positive trend, with a 7.40% growth in free cash flow in the TTM period. The operating cash flow to net income ratio of 0.66 and free cash flow to net income ratio of 0.96 indicate strong cash generation relative to earnings. Continued focus on cash flow management will support future investments and debt reduction.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.27B1.15B1.06B951.12M864.50M764.77M
Gross Profit415.24M375.02M339.88M299.74M269.85M226.24M
EBITDA135.36M120.61M106.56M83.14M80.70M57.18M
Net Income82.97M73.60M62.52M46.02M45.13M33.13M
Balance Sheet
Total Assets1.41B1.41B1.02B937.99M947.59M892.58M
Cash, Cash Equivalents and Short-Term Investments91.18M98.91M64.79M79.96M168.90M145.08M
Total Debt222.25M273.13M175.18M178.05M263.55M239.67M
Total Liabilities387.08M442.14M317.73M304.45M373.24M373.91M
Stockholders Equity1.02B970.49M706.69M633.54M574.34M518.68M
Cash Flow
Free Cash Flow96.79M110.38M102.79M96.81M34.84M102.58M
Operating Cash Flow100.42M116.43M112.25M105.11M39.49M109.41M
Investing Cash Flow-356.09M-354.61M-119.24M-106.59M-42.02M-214.24M
Financing Cash Flow173.54M272.30M-8.18M-87.45M26.34M138.19M

Addus Homecare Technical Analysis

Technical Analysis Sentiment
Negative
Last Price114.19
Price Trends
50DMA
115.31
Negative
100DMA
113.70
Negative
200DMA
110.13
Positive
Market Momentum
MACD
0.02
Positive
RSI
43.93
Neutral
STOCH
30.28
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADUS, the sentiment is Negative. The current price of 114.19 is below the 20-day moving average (MA) of 118.16, below the 50-day MA of 115.31, and above the 200-day MA of 110.13, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 43.93 is Neutral, neither overbought nor oversold. The STOCH value of 30.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ADUS.

Addus Homecare Risk Analysis

Addus Homecare disclosed 31 risk factors in its most recent earnings report. Addus Homecare reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Addus Homecare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$2.22B24.448.58%18.77%6.88%
73
Outperform
$1.94B18.6310.65%1.97%25.19%13.44%
69
Neutral
$873.73M32.3310.87%29.89%10.33%
61
Neutral
$1.67B132.651.29%68.17%-85.23%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
43
Neutral
$312.39M-73.31%5.21%5.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ADUS
Addus Homecare
113.08
-14.50
-11.37%
NHC
National Healthcare
127.17
-4.16
-3.17%
ASTH
Astrana Health
25.54
-21.42
-45.61%
PNTG
Pennant Group
25.54
-7.88
-23.58%
AGL
Agilon Health
0.67
-1.17
-63.59%

Addus Homecare Corporate Events

Financial DisclosuresM&A Transactions
Addus HomeCare Reports Strong Q3 2025 Financial Results
Positive
Nov 3, 2025

On November 3, 2025, Addus HomeCare Corporation announced its financial results for the third quarter of 2025, showing a 25.0% increase in net service revenues to $362.3 million and a 31.6% rise in adjusted EBITDA to $45.1 million compared to the same period in 2024. The company completed the acquisition of Del Cielo Home Care Services on October 1, 2025, expanding its personal care operations in Texas, which is expected to positively impact its financial results and market coverage.

The most recent analyst rating on (ADUS) stock is a Buy with a $132.00 price target. To see the full list of analyst forecasts on Addus Homecare stock, see the ADUS Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
Addus Homecare Appoints New President and COO
Positive
Aug 7, 2025

On August 4, 2025, Addus HealthCare, a subsidiary of Addus HomeCare Corporation, announced the appointment of Heather Dixon as President and Chief Operating Officer, effective September 15, 2025. Dixon, who brings extensive experience in healthcare leadership, succeeds W. Bradley Bickham, who will transition to an advisory role until his retirement in March 2026. Dixon’s appointment is expected to bolster Addus’s operational excellence and support its growth strategy. Her previous roles include CFO positions at Acadia Healthcare and Everside Health, and she has served as an independent director for Addus since March 2023.

The most recent analyst rating on (ADUS) stock is a Buy with a $147.00 price target. To see the full list of analyst forecasts on Addus Homecare stock, see the ADUS Stock Forecast page.

Addus HomeCare Reports Strong Q2 2025 Growth
Aug 6, 2025

Addus HomeCare Corporation is a provider of home care services, primarily offering personal care, hospice, and home health services across 23 states in the United States. The company focuses on assisting individuals who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill, and disabled.

Addus HomeCare Earnings Call Highlights Growth Amid Challenges
Aug 6, 2025

The recent earnings call for Addus HomeCare Corporation painted a generally positive picture, with strong revenue growth and strategic acquisitions taking center stage. Despite some challenges, such as clinical hiring difficulties and concerns over CMS’s proposed payment changes, the overall sentiment leaned towards optimism, with the positive developments slightly outweighing the negatives.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 04, 2025